食品伙伴网讯 据欧盟食品安全局（EFSA）消息，2014年5月14日，欧盟食品安全局就转基因米曲霉菌株生产的木聚糖酶发布意见。
欧盟专家组经过评估得出结论认为，由转基因米曲霉菌株生产的木聚糖酶发生食物过敏反应的可能性很低，因此不会造成安全问题。
在审查了转基因过程、生产工艺、组分以及生化数据，以及毒理学数据之后，专家组认为这种酶在特定使用条件下不会造成健康问题。
部分原文报道如下：
Following a request from the European Commission, the EFSA Panel on Food Contact Material, Enzymes, Flavourings and Processing Aids （CEF Panel） was asked to deliver a scientific opinion on the food enzyme xylanase （endo-1,4-β-xylanase; EC 3.2.1.8） produced with the genetically modified Aspergillus oryzae strain NZYM-FB.
The CEF Panel considers that the likelihood of food allergic reactions to the xylanase produced with this genetically modified strain of Aspergillus oryzae is low and therefore does not raise safety concerns.
Based on the genetic modifications performed, the manufacturing process, the compositional and biochemical data provided and the toxicological studies, the Panel concluded that this food enzyme does not raise safety concern under the intended conditions of use.
原文链接：<http://www.efsa.europa.eu/en/efsajournal/pub/3645.htm>
本文由食品伙伴网编译，供网友参考，食品伙伴网提供欧盟、美国、英国、俄罗斯、日本、韩国、东南亚、西班牙等国家或地区的进出口合规咨询服务，欢迎垂询：0535-2129301，Email：vip@foodmate.net、news@foodmate.net.
地区：
